(de-news.net) – BioNTech, the biopharmaceutical company headquartered in Mainz, has formally announced its intention to acquire CureVac, a biotechnology firm based in Tübingen, with the…

The federal government takes a share in CureVac in order to promote the development of a vaccine against the Coronavirus. As Federal Minister of Economics…